The publisher's Medical Devices sector report, “Peripheral Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Peripheral Vascular Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Peripheral Vascular Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Vascular Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Peripheral Vascular Stents Overview
3 Products under Development
3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development
3.2 Peripheral Vascular Stents - Pipeline Products by Segment
3.3 Peripheral Vascular Stents - Pipeline Products by Territory
3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path
3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
3.6 Peripheral Vascular Stents - Ongoing Clinical Trials
4 Peripheral Vascular Stents - Pipeline Products under Development by Companies
4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development
5 Peripheral Vascular Stents Companies and Product Overview
6 Peripheral Vascular Stents- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Peripheral Vascular Stents - Pipeline Products by Stage of Development
- Peripheral Vascular Stents - Pipeline Products by Segment
- Peripheral Vascular Stents - Pipeline Products by Territory
- Peripheral Vascular Stents - Pipeline Products by Regulatory Path
- Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
- Peripheral Vascular Stents - Ongoing Clinical Trials
- Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
- Peripheral Vascular Stents - Pipeline Products by Stage of Development
- Glossary
- Peripheral Vascular Stents - Pipeline Products by Stage of Development
- Peripheral Vascular Stents - Pipeline Products by Segment
- Peripheral Vascular Stents - Pipeline Products by Territory
- Peripheral Vascular Stents - Pipeline Products by Regulatory Path
- Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
- Peripheral Vascular Stents - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Biotek LLC
- Abbott Vascular Inc
- Acotec Scientific Holdings Ltd
- amg International GmbH
- AndraTec GmbH
- Arterius Ltd
- Biotyx Medical (Shenzhen) Co Ltd
- Boston Scientific Corp
- Cardinal Health Inc
- Cook Medical Inc
- Cordis Corp
- CorInnova, Inc.
- Cytograft Tissue Engineering Inc (Inactive)
- Efemoral Medical LLC
- Efferent Labs Inc
- Electroformed Stents Inc
- Elixir Medical Corp
- Endomimetics LLC
- FIT Biotech Oy (Inactive)
- HeMo Bioengineering Ltd
- ID Nest Medical SAS
- InspireMD Inc
- Intressa Vascular SA
- Kyoto Medical Planning Co Ltd
- LeoMed, LLC
- Lepu Medical Technology (Beijing) Co Ltd
- LimFlow SA
- Lyra Therapeutics Inc
- Meril Life Sciences Pvt Ltd
- Micell Technologies Inc
- Micro Medical Solutions Inc
- Natec Medical Ltd
- Nipro Corp
- NSVascular, Inc.
- OrbusNeich
- PeriTec Biosciences Ltd
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Reflow Medical, Inc.
- Shanghai Bio-heart Biological Technology Co Ltd
- Shanghai Changde Medical Technology Co Ltd
- Shanghai MicroPort Endovascular MedTech Co Ltd
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Suzhou Yinluo Medical Devices Co Ltd
- Synergy Flow Ltd
- Tepha Inc
- TissueGen Inc
- Tractivus SL
- University of Michigan
- University of Pittsburgh
- University of Pittsburgh Medical Center
- Vascular Bioresorbable Technologies
- Vascular Concepts Ltd
- Vesper Medical Inc
- Vinnova
- VueKlar Cardiovascular Ltd (Inactive)
- Wake Forest University Health Sciences
- Xenogenics Corporation
- Zorion Medical
- Zylox-Tonbridge Medical Technology Co Ltd
